Episodes

  • Glaucoma 2026: Which emerging technologies will change practice?
    Dec 23 2025
    Joel Schuman, MD, of Wills Eye Hospital in Philadelphia, sits down with Sheryl Stevenson, executive editor of the Eye Care Network, for a discussion about emerging technologies that may influence glaucoma care as clinicians look toward 2026.

    Schuman highlights artificial intelligence for imaging and risk prediction, noting that “the performance really rivals expert readers and the regulatory pathways are clear.” He also reviews remote monitoring, sustained-release drug delivery, and procedural innovations such as direct selective laser trabeculoplasty.

    Addressing adoption challenges, Schuman outlines evidence, workflow, economics, and interoperability as key factors, noting that “The winners don’t have to be the flashiest tools in 2026. They’ll be the ones that make a busy clinic run better.”

    Show More Show Less
    19 mins
  • Customized Clarity: Navigating IOL Options for Optimal Patient Care
    30 mins
  • The Evolution of MacTel Management: Integrating Neuroprotective Therapies Into Clinical Practice
    28 mins
  • Eichenbaum Acorns: Inside the mindset of an early adopter with Jordan Graff, MD
    Nov 24 2025
    Eichenbaum Acorns is an editorially independent series powered by Modern Retina® and hosted by David A. Eichenbaum, MD, FASRS, partner and director of research at Retina Vitreous Associates of Florida in Tampa. This Q&A-style article and podcast series explore the overlooked corners of the retina specialist profession through candid conversations with thought leaders. Eichenbaum is the German translation for oak tree, and the aim of this series is to plant acorns of insight that grow into oaks of understanding.

    In this installment, Eichenbaum chats with Jordan M. Graff, MD, FACS, of Barnet Dulaney Perkins Eye Center in Phoenix, Arizona, to discuss the realities of early adoption in retina care. Graff’s experience with the port delivery system (PDS) (Susvimo; Genentech), first as an investigator and later as one of the most active commercial utilizers in the US, provides insight into the opportunities and challenges of early adoption. He has navigated both the initial excitement of innovation and the realities of setbacks, including Genentech’s October 2022 voluntary recall following septum dislodgement issues. With the July 2024 reintroduction of a revised product, Graff offers a perspective on resuming adoption post-recall.

    Show More Show Less
    13 mins
  • Tsu Shan Chambers on "My Eyes" film: Bringing inherited eye disease to the screen
    Nov 6 2025
    My Eyes, an Australian film created by actor, writer, and producer—and practicing optometrist—Tsu Shan Chambers, highlights the real-world challenges faced by families managing inherited eye disease and vision impairment. The Eye Care Network sat down with Chambers to discuss the film’s development and its role in raising awareness of eye health, particularly in relation to genetic conditions such as retinitis pigmentosa.

    Note: The film initially premiered in markets including Australia and New Zealand and is now widely available on Amazon Prime Video. Updates on future screenings can be found by following FanForce.



    Show More Show Less
    11 mins
  • Beyond The Walls: The “how and why” behind what drives today’s ophthalmologists
    Nov 6 2025
    In this inaugural episode of the Ophthalmology Times® “Beyond The Walls” podcast, host Deborah Ristvedt, DO, of Vance Thompson Vision, welcomes Marguerite B. McDonald, MD, FACS, a trailblazer in refractive surgery, dry eye research, and ophthalmic leadership.

    The conversation traces McDonald’s journey from childhood experiences with severe myopia to her pioneering role in laser vision correction, as well as ongoing research and advice for the next generation of eye care professionals. McDonald is clinical professor of ophthalmology at NYU Langone Medical Center in New York and Tulane University Health Sciences Center in New Orleans, and in practice at OCLI Vision in Oceanside, NY.

    Show More Show Less
    20 mins
  • Eichenbaum Acorns: A leadership conversation with Rishi P. Singh, MD, FASRS, on advancing CME
    Oct 2 2025
    Welcome to “Eichenbaum Acorns,” an editorially independent series powered by Modern Retina® and hosted by David A. Eichenbaum, MD, FASRS, partner and director of research at Retina Vitreous Associates of Florida in Tampa Bay. This series explores the overlooked corners of the retina specialist profession through candid conversations with thought leaders. Eichenbaum is the German translation for oak tree, and the aim of this series is to plant acorns of insight that grow into oaks of understanding.

    In this inaugural installment, Eichenbaum sits down with Rishi P. Singh, MD, FASRS, to unpack the art and strategy behind building enduring continuing medical education (CME) programs.

    Show More Show Less
    13 mins
  • NK Insights: An Interactive Corneal Sensitivity Testing Workshop
    Aug 29 2025
    In this podcast, experts John D. Gelles, OD, FAAO, FIAOMC, FCLSA, FSLS, FBCLA; and John Hovanesian, MD, FACS; discuss the importance of comprehensive strategies when performing corneal sensitivity testing in patients suspected of having neurotrophic keratitis (NK).
    Show More Show Less
    33 mins